One in four people with high blood pressure not taking their meds properly

April 2, 2014, British Medical Journal

Around one in four people prescribed drugs to lower longstanding blood pressure either just doesn't take them at all or only part of the time, suggests a study of a simple technique designed to find out why drug treatment might not be working in these patients, and published online in the journal Heart.

Those referred for further treatment, because of "resistant " were most likely not to be taking their tablets properly, the findings show.

It is well known that with common longstanding conditions don't always comply with their treatment, and is no exception. But until now there has been no easy way of finding out who is simply not taking their prescribed tablets and who is genuinely not responding to treatment.

The authors therefore analysed the urine samples of 208 patients with high blood pressure attending a specialist hypertension clinic. Some 125 were new referrals from primary care; 66 were follow up patients whose was poor; and 17 had been referred for .

Renal denervation is a procedure that cauterises nerve endings in the kidney artery walls, with the aim of lowering longstanding high blood pressure after comprehensive has apparently failed to do so, known as "resistant hypertension."

The urine samples were analysed for a wide range of the most commonly prescribed drugs to treat high blood pressure, using a widely available technique called high performance liquid chromatography-tandem mass spectrometry or HP LC-MS/MS, for short.

One in four of the 208 patients was not taking their properly: one in 10 (10%) was not complying with treatment at all; while a further one in seven (15%) was only taking them part of the time.

The greatest proportion of complete "untakers" was found among those referred for renal denervation, almost one in four of whom had no evidence whatsoever of any antihypertensive drugs in their urine.

Furthermore, the average number of drugs picked up in the was lower than the number actually prescribed. And there was a direct correlation between readings and the number of drugs detected, with the lowest readings among those taking all their prescribed meds.

The authors acknowledge their sample size is small, but point to "alarmingly high levels" of complete non-adherence to prescribed drugs.

"A majority of these patients in any secondary/tertiary care centre would routinely undergo many additional tests and procedures in search of the explanation for their apparent unresponsiveness to standard therapy prescribed in primary care," they emphasise, adding that in around one in five cases, HP LC-MS/MS could potentially avoid all this.

In an accompanying editorial, Professor Morris Brown, of the Clinical Pharmacology Unit at the University of Cambridge, says that the technique could "solve at a stroke the problem of monitoring adherence and should rapidly transform practice."

"Non-adherence to therapy, and its recognition, is a particular problem in hypertension because of its chronicity and asymptomatic nature," he writes.

"That most patients do not take all their drugs all the time was probably predictable," he suggests. "But that 23% of those referred for renal denervation have no detectable drug in their urine was a shock," he adds, especially given that there are considerable doubts about the effectiveness of this procedure, to say nothing of the waste of resources involved.

Explore further: Renal denervation shows no benefit in resistant hypertension

More information: High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis, Online First, DOI: 10.1136/heartjnl-2013-305063

Resistant hypertension: resistance to treatment or resistance to taking treatment? Online First, DOI: 10.1136/heartjnl-2014-305540

Related Stories

Renal denervation shows no benefit in resistant hypertension

March 31, 2014
Renal denervation fell short of primary and secondary efficacy goals in patients with severe resistant hypertension but did meet the primary safety endpoints, according to keenly awaited data from SYMPLICITY HTN-3 presented ...

Renal denervation patient registry finds low rate of adverse events

March 31, 2014
Patients with uncontrolled high blood pressure treated with renal denervation had low rates of adverse events and significant lowering of blood pressure at six months, according to a registry-based study presented at the ...

Kidney procedure might help ease tough-to-treat high blood pressure

November 20, 2013
(HealthDay)—A new therapy may help lower tough-to-treat high blood pressure in people with chronic kidney disease, a new study finds.

Standard kidney drug treatment works better than new surgical procedure

March 10, 2014
A simple surgical procedure on the kidneys touted as a revolutionary treatment for high blood pressure turns out to be not so revolutionary after all. In a first its kind, a Norwegian clinical trial shows that established, ...

Novel therapy fails for lowering blood pressure

March 29, 2014
An experimental therapy that was once hailed as a possible cure for people whose high blood pressure does not respond to medication, has been shown to be ineffective, a US study said Saturday.

Renal denervation achieves significant and sustained blood pressure reduction

August 27, 2012
Renal denervation leads to significant and sustained blood pressure reduction for up to 18 months in patients with treatment resistant hypertension, according to research presented at ESC Congress 2012. The new clinical data ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.